Presence of circulating macromolecular IgA in patients with hematuria due to primary IgA nephropathy.
The relation between renal histologic features and the presence of circulating immune complexes was studied in 50 patients with hematuria. Primary IgA nephropathy was found in 25 patients, and various other forms of glomerulopathy were seen in the remaining 25 patients. Circulating immune complexes were detected with the 125I-C1q-binding assay, the conglutinin-binding assay, and the anti-IgA inhibition binding assay, the latter detecting specifically IgA-containing immune complex-like material. The 125I-C1q-binding assay gave negative findings for all patients except one. With the conglutinin-binding assay, immune complexes were found in a similar frequency for patients with and without IgA nephropathy. However, the anti-IgA inhibition binding assay gave positive results only in patients with primary IgA nephropathy (68 percent) and in none of the other patients. Sucrose density ultracentrifugation, as well as experiments in which the anti-IgA inhibition binding assay was performed with and without pretreatment of serum with polyethylene glycol, showed the presumed IgA immune complexes to have intermediate sedimentation coefficients (11 to 21S). The presence and level of this macromolecular IgA in the circulation correlated significantly (p less than 0.001) with the presence of hematuria in patients who had this clinical manifestation intermittently. Furthermore, a significant correlation (r = 0.69, p less than 0.0001) was found between the degree of hematuria and the degree of positive findings of the anti-IgA inhibition binding assay. This study shows that in patients presenting with hematuria, a positive finding on the anti-IgA inhibition binding assay is restricted to patients with primary IgA nephropathy and therefore could be of diagnostic value.
D001666:Binding Sites, Antibody; D002499:Centrifugation, Density Gradient; D003166:Complement Activating Enzymes / Q000032:analysis; D015922:Complement C1q; D003168:Complement Fixation Tests; D005921:Glomerulonephritis / Q000276:immunology; D006417:Hematuria / Q000209:etiology / Q000276:immunology*; D006801:Humans; D007105:Immune Complex Diseases / Q000150:complications*; D007070:Immunoglobulin A / Q000032:analysis*; D007457:Iodine Radioisotopes; D007674:Kidney Diseases / Q000150:complications*; D008137:Longitudinal Studies; D046911:Macromolecular Substances
D007070:Immunoglobulin A; D007457:Iodine Radioisotopes; D046911:Macromolecular Substances; D015922:Complement C1q; D003166:Complement Activating Enzymes